Agency Forms Undergoing Paperwork Reduction Act Review, 4991-4992 [2020-01380]
Download as PDF
<![CDATA[
4991
Federal Register / Vol. 85, No. 18 / Tuesday, January 28, 2020 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
Hospital Chief Executive Officer .......
Ancillary Service Executive ...............
Medical Record Clerk .......................
Hospital Induction Data Collection ...
Ambulatory Unit Induction (ED only)
Retrieving Patient Records (ED
only).
Reabstraction Telephone interview
(ED only).
410
820
410
1
1
100
30/60
15/60
1/60
205
205
683
125
1
15/60
31
...........................................................
........................
........................
........................
1,124
Ancillary Service
interview.
Executive—Re-
Total ...........................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–01383 Filed 1–27–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–20–1158]
Agency Forms Undergoing Paperwork
Reduction Act Review
jbell on DSKJLSW7X2PROD with NOTICES
Number of
responses
per
respondent
Number of
respondents
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled, ‘‘CDC Ideation
Catalyst (I-Catalyst) Program and
Customer Engagement Information
Collection’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on October
25, 2019 to obtain comments from the
public and affected agencies. CDC
received one comment. This notice
serves to allow an additional 30 days for
public and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
VerDate Sep<11>2014
17:02 Jan 27, 2020
Jkt 250001
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
CDC Ideation Catalyst (I-Catalyst)
Program and Customer Engagement
Information Collection (OMB Control
No. 0920–1158, Exp. 1/31/2020)—
Revision—Office of Science, Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The CDC Office of Technology and
Innovation (OTI), located within CDC’s
Office of Science (OS), fosters
innovative science and promotes the
testing and implementation of
innovative ideas that improve CDC’s
ability to have public health impact. To
arm CDC staff with an expanded skillset and tools to evaluate and translate
their insights and ideas into solutions,
CDC developed an experiential
innovation curriculum and consultation
service called Ideation Catalyst (ICatalyst). The program was created with
the belief that innovation should be
customer-driven, based on user
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
research, and enhanced by the
engagement of people at all levels of an
organization. CDC also obtained OMB
approval for a generic clearance to
support the collection of information
from stakeholders and customers,
utilizing I-Catalyst program principles
and methodology (CDC I-Catalyst
Program, OMB No. 0920–1158, exp. date
1/31/2020).
The goal of the I-Catalyst program and
service is to help CDC explore, develop,
and test new approaches to solving
public health problems through a
discovery, ideation, and prototyping
process. I-Catalyst offers a process for
defining problems and engaging
stakeholders that improves the quality,
efficiency, and performance of
innovative solutions. Through the ICatalyst process, teams of CDC program
representatives, in consultation with
OTI, work with stakeholders to define
and articulate a problem and to identify
potentially effective solutions.
Participating teams go through a
hypothesis-testing, scientific method of
discovery to gather important insights
and identify technical or contextual
issues associated with defining a
problem or implementing a solution.
Teams are forced ‘‘out of the classroom’’
to conduct interviews, study customer/
stakeholder needs, collect feedback, and
find partnership opportunities. Only
conversations with potential customers/
stakeholders can provide the facts from
which hypotheses are proven or
disproven about whether a solution (i.e.,
a product, process, etc.) creates value for
the intended customer/stakeholder.
CDC estimates that an average of 10–
20 project teams will participate in the
I-Catalyst process per year. On average,
each team will collect information from
approximately 25 customers/
stakeholders (a total of 500 respondents
per year). Information will be collected
primarily through on-site, unstructured
interviews with individuals who
represent the customers or stakeholders
CDC teams are attempting to serve or
benefit. CDC may also collect
E:\FR\FM\28JAN1.SGM
28JAN1
4992
Federal Register / Vol. 85, No. 18 / Tuesday, January 28, 2020 / Notices
information through telephone
interviews, questionnaires, or webbased surveys. The estimated average
burden per response may vary from 20–
60 minutes, with an average of 30
minutes. Information to be collected
includes respondents’ perspectives
regarding needs, values, and barriers
relevant to developing potential
solutions.
CDC expects that teams participating
in the I-Catalyst process and OTI
consultations will be empowered to
implement innovative strategies and
solutions that create value for their
stakeholders. The ultimate goal is to
provide CDC staff with real-world,
hands-on training and the skills needed
to create value-based solutions that
benefit society and broaden the agency’s
impact.
In this Revision request, CDC seeks
approval for minor changes to the ICatalyst generic clearance. (1) The total
number of respondents and burden
hours will decrease based on
participation in the I-Catalyst process
during the period 2017–2019. Projectspecific estimates will be included with
each submission under the I-Catalyst
generic clearance. (2) CDC/ATSDR
programs may request OTI approval to
use the I-Catalyst generic if (a) program
representatives completed relevant OTI
training in 2017–2019, (b) program
representatives participate in relevant
OTI training or mentored technical
assistance in 2020–2022, or (c) OTI
determines that project goals and
methodology are consistent with the ICatalyst process. These changes will
allow OTI to make the OMB approval
process easier for a broader pool of
qualified customer discovery projects.
(3) The title of the clearance is being
updated to reflect its use by additional
CDC/ATSDR project teams approved by
OTI.
The I-Catalyst clearance will continue
to be used for information collections
necessary to explore the needs and
preferences of specific stakeholder
groups, and to improve the impact of
CDC products, programs, and
technologies. All projects submitted to
OMB for approval under the I-Catalyst
generic clearance will be consistent
with CDC/OTI goals for promoting
scientific innovation and customer
engagement in public health.
OMB approval is requested for three
years. Participation is voluntary and
there are no costs to respondents other
than their time. The total estimated
annualized burden hours are 250.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Form name
Number of
respondents
Number of
responses
per
respondent
Average
burden per
response
(in hours)
External Partners, Stakeholders, or Customers.
Interview Guides, Questionnaires, and Surveys.
500
1
30/60
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–01380 Filed 1–27–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–416 and CMS–
10227]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Comments on the collection(s) of
information must be received by the
OMB desk officer by February 27, 2020.
DATES:
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
jbell on DSKJLSW7X2PROD with NOTICES
VerDate Sep<11>2014
17:02 Jan 27, 2020
Jkt 250001
When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806 OR, Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
ADDRESSES:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
SUMMARY:
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
1. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
2. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
E:\FR\FM\28JAN1.SGM
28JAN1
]]>Agencies
[Federal Register Volume 85, Number 18 (Tuesday, January 28, 2020)]
[Notices]
[Pages 4991-4992]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01380]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-20-1158]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled, ``CDC Ideation Catalyst (I-Catalyst) Program
and Customer Engagement Information Collection'' to the Office of
Management and Budget (OMB) for review and approval. CDC previously
published a ``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on October 25, 2019 to obtain comments from
the public and affected agencies. CDC received one comment. This notice
serves to allow an additional 30 days for public and affected agency
comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
CDC Ideation Catalyst (I-Catalyst) Program and Customer Engagement
Information Collection (OMB Control No. 0920-1158, Exp. 1/31/2020)--
Revision--Office of Science, Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
The CDC Office of Technology and Innovation (OTI), located within
CDC's Office of Science (OS), fosters innovative science and promotes
the testing and implementation of innovative ideas that improve CDC's
ability to have public health impact. To arm CDC staff with an expanded
skill-set and tools to evaluate and translate their insights and ideas
into solutions, CDC developed an experiential innovation curriculum and
consultation service called Ideation Catalyst (I-Catalyst). The program
was created with the belief that innovation should be customer-driven,
based on user research, and enhanced by the engagement of people at all
levels of an organization. CDC also obtained OMB approval for a generic
clearance to support the collection of information from stakeholders
and customers, utilizing I-Catalyst program principles and methodology
(CDC I-Catalyst Program, OMB No. 0920-1158, exp. date 1/31/2020).
The goal of the I-Catalyst program and service is to help CDC
explore, develop, and test new approaches to solving public health
problems through a discovery, ideation, and prototyping process. I-
Catalyst offers a process for defining problems and engaging
stakeholders that improves the quality, efficiency, and performance of
innovative solutions. Through the I-Catalyst process, teams of CDC
program representatives, in consultation with OTI, work with
stakeholders to define and articulate a problem and to identify
potentially effective solutions. Participating teams go through a
hypothesis-testing, scientific method of discovery to gather important
insights and identify technical or contextual issues associated with
defining a problem or implementing a solution. Teams are forced ``out
of the classroom'' to conduct interviews, study customer/stakeholder
needs, collect feedback, and find partnership opportunities. Only
conversations with potential customers/stakeholders can provide the
facts from which hypotheses are proven or disproven about whether a
solution (i.e., a product, process, etc.) creates value for the
intended customer/stakeholder.
CDC estimates that an average of 10-20 project teams will
participate in the I-Catalyst process per year. On average, each team
will collect information from approximately 25 customers/stakeholders
(a total of 500 respondents per year). Information will be collected
primarily through on-site, unstructured interviews with individuals who
represent the customers or stakeholders CDC teams are attempting to
serve or benefit. CDC may also collect
[[Page 4992]]
information through telephone interviews, questionnaires, or web-based
surveys. The estimated average burden per response may vary from 20-60
minutes, with an average of 30 minutes. Information to be collected
includes respondents' perspectives regarding needs, values, and
barriers relevant to developing potential solutions.
CDC expects that teams participating in the I-Catalyst process and
OTI consultations will be empowered to implement innovative strategies
and solutions that create value for their stakeholders. The ultimate
goal is to provide CDC staff with real-world, hands-on training and the
skills needed to create value-based solutions that benefit society and
broaden the agency's impact.
In this Revision request, CDC seeks approval for minor changes to
the I-Catalyst generic clearance. (1) The total number of respondents
and burden hours will decrease based on participation in the I-Catalyst
process during the period 2017-2019. Project-specific estimates will be
included with each submission under the I-Catalyst generic clearance.
(2) CDC/ATSDR programs may request OTI approval to use the I-Catalyst
generic if (a) program representatives completed relevant OTI training
in 2017-2019, (b) program representatives participate in relevant OTI
training or mentored technical assistance in 2020-2022, or (c) OTI
determines that project goals and methodology are consistent with the
I-Catalyst process. These changes will allow OTI to make the OMB
approval process easier for a broader pool of qualified customer
discovery projects. (3) The title of the clearance is being updated to
reflect its use by additional CDC/ATSDR project teams approved by OTI.
The I-Catalyst clearance will continue to be used for information
collections necessary to explore the needs and preferences of specific
stakeholder groups, and to improve the impact of CDC products,
programs, and technologies. All projects submitted to OMB for approval
under the I-Catalyst generic clearance will be consistent with CDC/OTI
goals for promoting scientific innovation and customer engagement in
public health.
OMB approval is requested for three years. Participation is
voluntary and there are no costs to respondents other than their time.
The total estimated annualized burden hours are 250.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
External Partners, Stakeholders, or Interview Guides, 500 1 30/60
Customers. Questionnaires, and
Surveys.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-01380 Filed 1-27-20; 8:45 am]
BILLING CODE 4163-18-P
